Impact of Recombinant DNA technology and Vector Biotechnology

In molecular cloning  method, a vector is small fragment of DNA molecule which is derived from viral, cell component which is used as a vehicle to artificially carry the foreign genetic material into another cell, where it can be replicated and/or expressed into new recombinant fragment (e.g. plasmid, cosmid, Lambda phages) has been created by the combination of at least two strands. A vector containing foreign DNA is termed recombinant DNA or chimeric DNA

Recombinant DNA (rDNA) molecules are formed by the different DNA fragment molecules which are prepared by laboratory methods of various genetic recombination’s to bring together genetic material from different multiple sources and creating a new sequences that would not otherwise be found in the genome.

 

  • Challenges in prevention of vector-borne diseases
  • Detection of molecular targets for drug development
  • Novel diagnostics strategies
  • Antiviral and antimicrobial treatment
  • Molecular detection (nucleic acid probes and nucleic acid amplification)

Related Conference of Impact of Recombinant DNA technology and Vector Biotechnology

January 21-22, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
August 16-17, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany

Impact of Recombinant DNA technology and Vector Biotechnology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in